Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint
Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis
Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis
The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines
Evidence for a transcriptional signature of breast cancer
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up
A dose- and time-controllable syngeneic animal model of breast cancer microcalcification
Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients
The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation
Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations
Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer
Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts
Induction of the small heat shock protein αB-crystallin by genotoxic stress is mediated by p53 and p73
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study
Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
Osteonecrosis of the jaw and bevacizumab therapy
SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls
Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point”
No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects
Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study
No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects
The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger
Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis
Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls
TNFα -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls
Transforming growth factor-β1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays
PALB2 mutations in male breast cancer: a population-based study in Central Italy
PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations